US Pfizer unlikely to make fresh bid for AstraZeneca
STOCKHOLM: Pfizer American multinational pharmaceutical is unlikely to come back with a fresh bid for AstraZeneca, the Anglo Swedish pharmaceuticals group's top ...
STOCKHOLM: Pfizer American multinational pharmaceutical is unlikely to come back with a fresh bid for AstraZeneca, the Anglo Swedish pharmaceuticals group's top ...
MUNICH: Pfizer, medicine manufacturing giant, beaten all its records in quarterly results, helped by growing sales of its cancer ...
LONDON: The Illinois-based company, AbbVie, will receive a break fee of 1.6 billion US dollars (£1 billion) once a meeting ...
© 2011 Customs Today -World's first newspaper on customs. Customs Today.
© 2011 Customs Today -World's first newspaper on customs. Customs Today.